SmarTrend's Market Wrap-up for Monday, April 4th

Investing Ideas (2)
Embedded Video: 

Boring day for stocks.  Pfizer (NYSE:PFE) and Texas Instruments (NYSE:TXN) were about the only noteworthy movers.

Time to Buy Pfizer Shares


Shares of Pfizer Inc. (NYSE:PFE) have flattened out a bit over the past two weeks, leaving the current trading price close to the 20-day moving average stock price.  This may prove to be a great time to invest in shares of the company as share price may bounce off the 20-day moving average to continue its uptrend.

The Value in Pfizer (NYSE:PFE)


Pfizer Inc. (NYSE:PFE) provides the sole competition to Johnson and Johnson in terms of market value. Consider this though, the large-cap pharmaceutical sector has underperformed the broad market for the past decade.

Market News for Yahoo, KeyCorp and Pfizer (NASDAQ:YHOO),(NYSE:KEY),(NYSE:PFE)


Stock market news for Yahoo! Inc. (NASDAQ:YHOO) includes a new director, KeyCorp (NYSE:KEY) sells notes, and Garth Anderson on Pfizer Inc. (NYSE:PFE)  Cancer Cures.

Merck Outshines Pfizer and J&J (NYSE:MRK),(NYSE:JNJ),(NYSE:PFE)


While it is true that in terms of sheer size (i.e. Market Cap), Pfizer Inc. (NYSE:PFE) and Johnson & Johnson (NYSE:JNJ) outweigh Merck & Co., Inc. (NYSE:MRK).  Although as investors, we care more about our own money than we do about the company’s market cap. 

Pfizer Review and Buy Watch (NYSE: PFE)


Pfizer Inc. (NYSE:PFE) is an attractive stock for its dividends and price appreciation.  Pfizer closed at $18.59 at the end of the trading day Wednesday and currently offers a dividend yield of 3.5%.  In addition, PFE has been in a steady, uptrending price channel since early March ’09 (see chart below).

Google Acquires, Pfizer Hurts and Retail is Cynical


Google Inc. (NASDAQ:GOOG) is shifting into high acquisition mode for 2009 and forward.  While Google announces this good news, Pfizer Inc. (NYSE:PFE) is feeling some pain over its roots to asbestos.  Then there is the retail world, which is

Bruce Berkowitz Conference Call

Bruce Berkowitz

The call focused on one company in the Fairholme fund Pfizer (NYSE:PFE). On the call was Jeff Kindler the CEO of Pfizer and Frank D’Amelio, CFO of Pfizer along with Fairholme's (NYSE:FAIRX) Berkowitz.

Jim Grant: What Ben Graham Would Buy

Ben Graham

Grant's brilliant...

Bruce Berkowitz Press Conference

Bruce Berkowitz

This is brilliant. One of todays's best investors gives his insight into his investments.

Syndicate content

WallStNation.comThanks for visiting, to assist your investing research try using our Search (click to access) or review the list of Tickers (click to access) that link directly to articles related to the given stock/security.

To Browse our Most Recent Stories (click here)

Share Content

Share this article with others, is the Independent Wall Street Newspaper. Thanks for Reading!

Daily Market Summary

Please Review the Disclaimer and remember that information provided by our site is at the investor's sole financial risk. Please Review for more Details